New Content  edit
Get The App!

CME/CE Certified On-Demand
Lecture Series

Upcoming Lectures

There are no meetings currently scheduled in this subject area.
If you are interested in this topic and would like a meeting scheduled in your local area please request a lecture by clicking the button above.
|
Speaker:
Topic:
Format:
Date:
Time:
Location:
Accreditation:


Practice Updates in Primary Myelofibrosis
Learning Objectives:
  • Apply current treatment recommendations for primary myelofibrosis (PMF)
  • Describe common adverse effects associated with JAK2 inhibitor therapy and appropriate management strategies
  • Identify clinical considerations to optimize switching among therapeutic options.

Advances in Polycythemia Vera: Managing Patients in 2020
Learning Objectives:
  • Discuss contemporary diagnostic criteria and risk stratification to outline treatment strategies and goals in PV
  • Apply current risk adapted treatment strategies to optimize first- and second-line treatment of patients with PV
  • Evaluate efficacy and safety data related to novel formulations and new therapies for the treatment of PV
  • Identify common adverse effects associated with cytoreductive therapies and appropriate management strategies

Addressing Challenges in Essential Thrombocythemia
Learning Objectives:
  • Apply current diagnostic criteria for ET and differentiate "true ET" from prefibrotic/early primary myelofibrosis (prePMF)
  • Utilize prognostic models and guidelines to inform risk-based treatment
  • Discuss strategies for patients with ET who are resistant to or intolerant of hydroxyurea



Accreditation Information

Joint Accreditation Statement
In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Total CME.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates each continuing education activity for 0.5 contact hour (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

  • Practice Updates in Primary Myelofibrosis - UAN: JA4008162-9999-20-2026-L01-P; 0.5 contact hour; Knowledge
  • Advances in Polycythemia Vera: Managing Patients in 2020- UAN: JA4008162-9999-20-2027-L01-P; 0.5 contact hour; Knowledge
  • Addressing Challenges in Essential Thrombocythemia - UAN: JA4008162-9999-20-2028-L01-P; 0.5 contact hour; Knowledge
For Pharmacists: You are not eligible to receive ACPE credit if you have previously attended and received credit for any of the above listed activities.

Continuing Nursing Education
The maximum number of hours awarded for each Continuing Nursing Education activity is 0.5 contact hour.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Target Audience
These activities have been designed to meet the educational needs of physicians, registered nurses, pharmacists and other healthcare professionals involved in the care of patients with myeloproliferative neoplasms (MPNs).

Fee Information
There is no fee for these educational activities.

Jointly provided by Postgraduate Institute for Medicine and Total CME

These activities are supported by an independent educational grant from Incyte Corporation



Available Formats

At this time, all IMPACT Live events are available as a webinar. Please check the scheduled lectures tab to register for upcoming events.

Pre-work Program/ Post-work Quiz
Live events utilize a closed-loop learning experience by providing pre-work programs and post-work quizzes to accompany the lecture events to ensure attendees of the lectures retain concepts taught. The flipped classroom pre-work episodes are developed specifically to introduce key information which may be applied during the live event and encourage engagement between the attendee and faculty. Pre-work is presented by expert faculty in several short, educational episodes. Post-work quizzes allow attendees to revisit topics for a better long-term retention and test their knowledge on concepts taught at the lecture.

Compliance with Sunshine Act
The National Physician Payment Transparency Program (Sunshine Act) is a section of the Patient Protection and Affordable Care Act of 2010 that requires pharmaceutical and medical device companies to report to the Federal government certain payments (e.g. meals and other meeting expenses) they make to physicians and teaching hospitals. IMPACT Live programs fully comply with the Sunshine Act and, as a result, payments may be reportable based upon these requirements. For detailed information, please visit www.cms.gov.



IMPACT MPN Faculty


Program Chair:

Srdan Verstovsek, MD, PhD
Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, TX


Faculty:

Prithviraj Bose, MD
Assistant Professor, Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Navel Daver, MD
Assistant Professor, Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Aaron Gerds, MD
Assistant Professor
Cleveland Clinic Taussig Cancer Institute
Cleveland, OH

Rami Komrokji, MD
Vice Chair, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, FL

John Mascarenhas, MD
Associate Professor of Medicine
Tisch Cancer Institute - Icahn School of Medicine at Mount Sinai
New York, NY

Ruben A. Mesa, MD, FACP
Director, Mays Cancer Center
UT Health San Antonio MD Anderson Cancer Center
San Antonio, TX

Casey L. O'Connell, MD
Associate Professor of Clinical Medicine, Div of Hematology
Keck School of Medicine of USC
Los Angeles, CA

Stephen T. Oh, MD, PhD
Assistant Professor, Division of Medicine - Hematology
Washington University School of Medicine
St. Louis, MO

Naveen Pemmaraju, MD
Associate Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center,
Houston, TX

Nikolai Podoltsev, MD, PhD
Assistant Professor, Division of Medicine
Department of Internal Medicine, Hematology Section
Associate Director of the Hematology/Oncology Fellowship Program
Yale University School of Medicine
New Haven, CT

Daniel A. Pollyea, MD, MS
Associate Professor of Medicine
Clinical Director of Leukemia Services
Robert H. Allen MD Chair in Hematology Research
Division of Hematology
University of Colorado School of Medicine
Aurora, CO

Raajit K. Rampal, MD
Assistant Attending Physician, Leukemia Service
Memorial Sloan-Kettering Cancer Center
New York, NY

Michael Savona, MD
Associate Professor of Medicine
Director of Hematology Research
Director, Hematology Early Therapeutics Program
Department of Medicine, Division of Hematology & Oncology
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, TN

Bart Scott, MD
Fred Hutchinson Cancer Research Center
University of Washington
Seattle Cancer Care Alliance
Seattle, WA

David S. Snyder, MD
Professor of Medicine
Associate Director, Department of Hematology/
Hematopoietic Cell Transplantation
City of Hope Cancer Center
Duarte, CA